CollectionsResearch
IN THE NEWS

Research

SPORTS
January 30, 2016 | By Matt Gelb, STAFF WRITER
Matt Klentak, in his first winter at the head of a baseball operations department, wanted to learn how companies manage information. The 35-year-old Phillies general manager surveyed people in baseball, other sports, and some with zero connections to the game. How, he asked, do you implement analytics into decisions? Those talks led him to Andy Galdi, a 30-year-old Google employee who was hired Thursday as the Phillies' first-ever director of baseball research and development. "He's the perfect guy to help grow us forward in this area," Klentak said.
NEWS
January 28, 2016 | By Stacey Burling, Staff Writer
After four - failed - auditions for American Idol , Junhow Wei got the message that he probably wasn't going to be a pop star. But Wei, who is now on the verge of getting his Ph.D. in sociology at the University of Pennsylvania, has found a way to turn his rejection into something positive: a study on how Idol losers deal with bad news. Wei's own reaction the first time he was rejected - anger - was a common one, he said. But, like lots of others, he also decided to try again, a tack he considers more in line with the "meritocratic" ideal that hard work and talent can triumph over lousy odds.
BUSINESS
January 22, 2016 | By Chris Mondics and Sam Wood, STAFF WRITERS
Two GlaxoSmithKline scientists and three others were charged by a federal grand jury in Philadelphia on Wednesday with conspiracy to steal promising cancer research secrets from the pharmaceutical giant and market them to companies in China backed by the Chinese government. U.S. Attorney Zane David Memeger said Yu Xue, 45, of Wayne; Tao Li, 42, and Yan Mei, 36, both of Nanjing China; Tian Xue, 45, of Charlotte, N.C.; and Lucy Xi, 38, of West Lake Village, Calif., were named in the indictment.
ENTERTAINMENT
January 16, 2016
Vice President Biden is scheduled to spend part of Friday afternoon at the University of Pennsylvania's Abramson Cancer Center, the first stop on his quest for the United States to cure cancer. President Obama announced the new "Moon Shot" mission during his State of the Union address Tuesday night, comparing it with John F. Kennedy's 1961 declaration to Congress that the nation would land a man on the moon by the end of the decade.Biden's 3 p.m. visit includes a tour of laboratories and a roundtable discussion with researchers at the Smilow Center for Translational Research and the Perelman Center for Advanced Medicine, both 3400 Civic Center Blvd.
BUSINESS
January 13, 2016
Scholars, shareholders, the newly separated, and the long-frustrated have plenty to say about cuts to the central research and business units at DuPont Co. by new CEO Edward Breen . Some highlights: "DuPont struggled with return on R&D over the years," notes Ben duPont , a shareholder and past manager at the chemical giant that bears his ancestor's name. "For 40 years, like a drumbeat, every few years DuPont introduced a new blockbuster product - nylon, Teflon, Tyvek, Delrin, Kevlar, Lycra, Kapton, Neoprene, Mylar . " (They weren't all blockbusters; duPont still has a pair of Corfam shoes - the Edsel of leather.)
NEWS
November 30, 2015 | By Kevin Riordan, Inquirer Columnist
A week after 22-year-old Nicholas Peter Zizzamia disappeared from his Cherry Hill home May 12, 1979, the body of a young man of similar build and appearance was found 580 miles away in a Richmond, Ind., motel room. The city's Palladium-Item newspaper reported that the man had apparently slashed his right wrist and bled to death watching TV. Authorities did not find a driver's license or other identification in the room, for which the deceased had anonymously paid $13.52 in cash the day before.
BUSINESS
November 24, 2015 | By Tom Avril, Inquirer Staff Writer
Solar panels accounted for one-third of all new electricity generation installed in the United States in 2014, up from just 10 percent two years earlier. With interest expected to keep rising, many research groups are on the hunt for ways to boost efficiency. Among them is a team at the University of Delaware, which is developing materials to harness portions of the sun's spectrum that in today's conventional solar panels are largely wasted. The key is a property of a panel's semiconductor material called the band gap, an electronic hurdle of sorts.
NEWS
November 19, 2015 | By Ilene Raymond Rush, For The Inquirer
When it comes to a still-mysterious condition known as Castleman disease, David Fajgenbaum, a professor of hematology/oncology at the University of Pennsylvania's Perelman School of Medicine, is more than an advocate or a physician/scientist: He is also a patient. Addressing a team of volunteers for the Castleman Disease Collaborative Network (CDCN), Fajgenbaum quickly details on a white board what is known about CD, a group of poorly understood inflammatory disorders that can vary from a single enlarged lymph node to life-threatening multiple organ failure.
NEWS
October 28, 2015 | By Andrew Seidman, Inquirer Trenton Bureau
Gov. Christie on Tuesday tapped a new state treasurer, filling one of several vacancies that opened in his cabinet after several officials left the administration in recent months. Ford M. Scudder, chief operating officer of Nashville-based Laffer Associates, will begin as treasurer next month, the governor's office said. He replaces Andrew Sidamon-Eristoff, who left in July. Scudder is also a senior research analyst at Laffer Investments, an investment management firm. The company's founder, Arthur Laffer, who also founded the economic research and consulting firm Laffer Associates, was a key economic adviser to President Ronald Reagan, and is often called the father of supply-side economics - a theory that elevates the role of lowering taxes over government spending in stimulating economic growth.
BUSINESS
October 19, 2015 | By David Sell, Inquirer Staff Writer
Elizabeth Grice, a University of Pennsylvania assistant professor, embodies the new way that academia and drug companies collaborate on research to generate cash for schools and profitable medicines for manufacturers. Grice, like many researchers, gets most of her funding from government agencies such as the National Institutes of Health and foundations. Like some, she also is doing work for a for-profit pharmaceutical company - in her case, Janssen Pharmaceuticals. What's changed in recent years is the nature of that academic-industry relationship.
« Prev | 1 | 2 | 3 | 4 | 5 | Next »
|
|
|
|
|